Ionis Pharmaceuticals, Inc. (IONS)
79.06
+0.20
(+0.25%)
USD |
NASDAQ |
Dec 10, 14:04
Ionis Pharmaceuticals Profit Margin (Quarterly): -82.06% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 19.00% |
| Merck & Co., Inc. | 33.68% |
| Pfizer Inc. | 21.32% |
| Eli Lilly & Co. | 31.72% |
| Cogent Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.01% |
| Return on Assets | -8.58% |
| Return on Invested Capital | -9.92% |
| Gross Profit Margin (Quarterly) | 96.67% |
| Operating Margin (Quarterly) | -102.2% |
| Return on Net Operating Assets | -75.84% |